According to Prothena's latest financial reports the company's current revenue (TTM) is $91.37 M. In 2022 the company made a revenue of $53.9 M a decrease over the years 2021 revenue that were of $0.20 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $91.37 M | 69.5% |
2022 | $53.9 M | -73.13% |
2021 | $0.20 B | 23414.3% |
2020 | $0.85 M | 4.79% |
2019 | $0.81 M | -14.76% |
2018 | $0.95 M | -96.53% |
2017 | $27.51 M | 2508.44% |
2016 | $1.05 M | -34.35% |
2015 | $1.6 M | -96.84% |
2014 | $50.85 M | 7422.78% |
2013 | $0.67 M | -74.57% |
2012 | $2.65 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Amarin Corporation
AMRN | $0.30 B | 235.90% | ๐ฎ๐ช Ireland |
Alnylam Pharmaceuticals
ALNY | $1.82 B | 1,900.98% | ๐บ๐ธ USA |
Alkermes ALKS | $1.66 B | 1,720.52% | ๐ฎ๐ช Ireland |